Fortress Biotech, Inc. SEC filings FBIO
Fortress Biotech, Inc. has 886 filings in SEC EDGAR's recent list, going back to Mar 5, 2008. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 17, 2025 | — |
| CORRESP | Letter to the SEC | Dec 16, 2025 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| EFFECT | Filing | Oct 7, 2024 | — |
| CORRESP | Letter to the SEC | Oct 2, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2024 | — |
| EFFECT | Filing | Jun 27, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2024 | — |
| EFFECT | Filing | May 30, 2024 | — |
| CORRESP | Letter to the SEC | May 29, 2024 | — |
| UPLOAD | Letter from the SEC | May 24, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2023 | — |
| CORRESP | Letter to the SEC | Oct 26, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2023 | — |
| CORRESP | Letter to the SEC | Jul 18, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2023 | — |
| EFFECT | Filing | Apr 13, 2023 | — |
| CORRESP | Letter to the SEC | Apr 13, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 15, 2023 | — |
| EFFECT | Filing | Dec 1, 2021 | — |
| EFFECT | Filing | Nov 4, 2021 | — |
| CORRESP | Letter to the SEC | Oct 19, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2021 | — |
| EFFECT | Filing | Jul 30, 2021 | — |
| EFFECT | Filing | Jul 30, 2021 | — |
| CORRESP | Letter to the SEC | Jul 29, 2021 | — |
| CORRESP | Letter to the SEC | Jul 29, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2021 | — |
| CORRESP | Letter to the SEC | Jul 28, 2021 | — |
| CORRESP | Letter to the SEC | Jul 28, 2021 | — |
| CORRESP | Letter to the SEC | Jul 23, 2021 | — |
| PX14A6G | Filing | Jun 2, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2021 | — |
| EFFECT | Filing | Nov 20, 2020 | — |
| CORRESP | Letter to the SEC | Nov 18, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2020 | — |
| PX14A6G | Filing | Jun 3, 2020 | — |
| EFFECT | Filing | May 26, 2020 | — |
| CORRESP | Letter to the SEC | May 26, 2020 | — |
| CORRESP | Letter to the SEC | May 26, 2020 | — |
| UPLOAD | Letter from the SEC | May 22, 2020 | — |
| UPLOAD | Letter from the SEC | May 1, 2020 | — |
| CORRESP | Letter to the SEC | Apr 28, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2020 | — |
| EFFECT | Filing | Jul 23, 2019 | — |
| CORRESP | Letter to the SEC | Jul 19, 2019 | — |
| CORRESP | Letter to the SEC | Jul 20, 2018 | — |
| D | Filing | Mar 13, 2018 | — |
| CERTNAS | Auto-generated paper document | Nov 8, 2017 | — |
| 8-A12B | Filing | Nov 7, 2017 | — |
| D | Filing | Apr 19, 2017 | — |
| EFFECT | Filing | Dec 1, 2016 | — |
| CORRESP | Letter to the SEC | Nov 29, 2016 | — |
| SC TO-T/A | Amendment no.2 to sc to-t | Sep 15, 2016 | — |
| SC TO-T/A | Filing | Sep 12, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2016 | — |
| SC TO-T | Filing | Aug 12, 2016 | — |
| SC TO-C | Form 8-k | Aug 12, 2016 | — |
| SC TO-C | Form 8-k | Apr 28, 2016 | — |
| EFFECT | Filing | Aug 19, 2013 | — |
| CT ORDER | Filing | May 31, 2013 | — |
| CT ORDER | Filing | Apr 30, 2013 | — |
| EFFECT | Filing | Oct 11, 2012 | — |
| EFFECT | Filing | Sep 28, 2012 | — |
| EFFECT | Filing | Jun 21, 2012 | — |
| CT ORDER | Filing | Jun 6, 2012 | — |
| CT ORDER | Filing | May 14, 2012 | — |
| CERTNAS | Auto-generated paper document | Dec 15, 2011 | — |
| 8-A12B | Form 8-a | Dec 7, 2011 | — |
| EFFECT | Filing | Nov 15, 2011 | — |
| CORRESP | Letter to the SEC | Nov 14, 2011 | — |
| UPLOAD | Letter from the SEC | Oct 6, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2011 | — |
| CT ORDER | Filing | Sep 23, 2011 | — |
| 10-12G/A | Amendment #3 | Sep 22, 2011 | — |
| 10-12G/A | Amendment no.2 to form 10 | Sep 9, 2011 | — |
| 10-12G/A | Amendment no. 1 to form 10 | Aug 23, 2011 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2011 | — |
| 10-12G | Filing | Jul 15, 2011 | — |
| D/A | Filing | Jul 5, 2011 | — |
| D | Filing | Jun 6, 2011 | — |
| D | Filing | May 9, 2011 | — |
| D | Filing | Feb 8, 2011 | — |
| D | Filing | Jan 19, 2011 | — |
| D | Filing | Jun 8, 2010 | — |
| D | Filing | May 7, 2010 | — |
| D | Filing | Aug 4, 2009 | — |
| REGDEX | Auto-generated paper document | Mar 5, 2008 | — |
Showing 92 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FBIO (Nasdaq), FBIOP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bay Harbor Islands, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1429260
- Former names
- Fortress Biotech, Inc. (until Oct 29, 2026); CORONADO BIOSCIENCES INC (until Apr 27, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.